Description

The U.S. Department of Justice published updates to its Evaluation of Corporate Compliance Programs. The document details with specificity the factors that prosecutors consider when investigating a corporation, determining whether to bring charges, and negotiating plea or other agreements. The time to review and implement this evaluation is before an investigation. From compliance program design to adequate resourcing to risk assessments and everything in between, learn what the DOJ expects from your compliance program and tips for how to meet those expectations.

Learning Objectives:

• Introduce the U.S. Department of Justice (DOJ) Evaluation of Corporate Compliance Programs (ECCP) Updated March 2023
• Understand the purpose and application of the ECCP
• Gain deep understanding of how to use the questions presented
• Discuss the structure of the guidance and how to use effectively
• Discuss documentation and decision-making based on the information

Areas Covered in the Session:

• Purpose and application
• DOJ guidelines
• Risk assessment
• Policies and procedures
• Training and communications
• Confidential reporting structure and investigation process
• Third party management
• Mergers and acquisitions
• Commitment by senior and middle management
• Autonomy and resources
• Compensation structures and consequence management
• Continuous improvement, periodic testing and review
• Investigation of misconduct
• Analysis and remediation of any underlying misconduct
• Practical tips for Implementation
• Live Q&A session

Attendees:

• Healthcare CEOs, CFOs and COOs
• Chief Compliance Officers
• Compliance Analysts and Specialists at Hospitals
• Home Health Agencies
• Clinical Laboratories
• Third Party Medical Billing Companies
• Durable Medical Equipment Industry
• Hospice
• Medicare Advantage Organizations
• Nursing Facilities
• Physicians
• Ambulance Suppliers
• Pharmaceutical Manufacturers
• Privacy Officers
• General Counsel
• Business Associates